Basal Cell Carcinoma — Trials

Basal Cell Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

361 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 57
Recruiting: 32
Ph III recruiting: 3
Growth YoY: —
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 16.5%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (25)

clinicaltrialsPublishedShowing 1–3 of 3 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05110924	RCT Treatment Versus Non Treatment of Low-risk BCCs in Elderly(BASINEL)	terminated	N/A	9	University Hospital, GhentOTHER	1	Dec 17, 2024	clinicaltrials
NCT03420846	Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping	terminated	N/A	86	Michelson Diagnostics Ltd.INDUSTRY	1	Jan 28, 2020	clinicaltrials